Cargando…
Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and affects approximately one third of adults in the United States. The disease is becoming a global epidemic as a result of the rising rates of obesity and metabolic disease. Emerging data suggest w...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641567/ https://www.ncbi.nlm.nih.gov/pubmed/32674529 http://dx.doi.org/10.3350/cmh.2020.0067 |
_version_ | 1783605943269851136 |
---|---|
author | Hydes, Theresa J. Ravi, Sujan Loomba, Rohit E. Gray, Meagan |
author_facet | Hydes, Theresa J. Ravi, Sujan Loomba, Rohit E. Gray, Meagan |
author_sort | Hydes, Theresa J. |
collection | PubMed |
description | Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and affects approximately one third of adults in the United States. The disease is becoming a global epidemic as a result of the rising rates of obesity and metabolic disease. Emerging data suggest weight loss of ≥10% overall body weight is beneficial in resolving steatosis and reversing fibrosis. Prospective trials comparing various diets are limited by lack of sufficient power as well as pre- and post-treatment histopathology, and therefore no specific diet is recommended at this time. In this narrative review we examine the pathophysiology behind specific macronutrient components that can either promote or reverse NAFLD to help inform more specific dietary recommendations. Overall, the data supports reducing saturated fat, refined carbohydrates, and red and processed meats in the diet, and increasing the consumption of plant-based foods. Diets that incorporate these recommendations include plant-based diets such as the Dietary Approaches to Stop Hypertension, Mediterranean, vegetarian, and vegan diets. |
format | Online Article Text |
id | pubmed-7641567 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Korean Association for the Study of the Liver |
record_format | MEDLINE/PubMed |
spelling | pubmed-76415672020-11-13 Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH Hydes, Theresa J. Ravi, Sujan Loomba, Rohit E. Gray, Meagan Clin Mol Hepatol Review Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and affects approximately one third of adults in the United States. The disease is becoming a global epidemic as a result of the rising rates of obesity and metabolic disease. Emerging data suggest weight loss of ≥10% overall body weight is beneficial in resolving steatosis and reversing fibrosis. Prospective trials comparing various diets are limited by lack of sufficient power as well as pre- and post-treatment histopathology, and therefore no specific diet is recommended at this time. In this narrative review we examine the pathophysiology behind specific macronutrient components that can either promote or reverse NAFLD to help inform more specific dietary recommendations. Overall, the data supports reducing saturated fat, refined carbohydrates, and red and processed meats in the diet, and increasing the consumption of plant-based foods. Diets that incorporate these recommendations include plant-based diets such as the Dietary Approaches to Stop Hypertension, Mediterranean, vegetarian, and vegan diets. The Korean Association for the Study of the Liver 2020-10 2020-07-17 /pmc/articles/PMC7641567/ /pubmed/32674529 http://dx.doi.org/10.3350/cmh.2020.0067 Text en Copyright © 2020 by The Korean Association for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Hydes, Theresa J. Ravi, Sujan Loomba, Rohit E. Gray, Meagan Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH |
title | Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH |
title_full | Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH |
title_fullStr | Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH |
title_full_unstemmed | Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH |
title_short | Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH |
title_sort | evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of nafld and nash |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641567/ https://www.ncbi.nlm.nih.gov/pubmed/32674529 http://dx.doi.org/10.3350/cmh.2020.0067 |
work_keys_str_mv | AT hydestheresaj evidencebasedclinicaladvicefornutritionanddietaryweightlossstrategiesforthemanagementofnafldandnash AT ravisujan evidencebasedclinicaladvicefornutritionanddietaryweightlossstrategiesforthemanagementofnafldandnash AT loombarohit evidencebasedclinicaladvicefornutritionanddietaryweightlossstrategiesforthemanagementofnafldandnash AT egraymeagan evidencebasedclinicaladvicefornutritionanddietaryweightlossstrategiesforthemanagementofnafldandnash |